Abstract
YKL-40 is secreted by macrophages, including those in atherosclerotic plaques, neutrophils, and vascular smooth muscle cells. Circulating YKL-40 is elevated in patients with inflammation and increased tissue remodeling. The aim was to examine the sequential changes in serum YKL-40 in patients with acute myocardial infarction (AMI), with and without thrombolytic therapy, as compared with patients with stable coronary artery disease (CAD).
Originalsprog | Engelsk |
---|---|
Tidsskrift | Coronary Artery Disease |
Vol/bind | 19 |
Udgave nummer | 4 |
Sider (fra-til) | 257-63 |
Antal sider | 7 |
ISSN | 0954-6928 |
DOI | |
Status | Udgivet - 2008 |